Abstract:Key Clinical Message This study aimed to characterize the clinical features, developmental milestones, and the natural history of Pelizaeus–Merzbacher disease (PMD) associated with PLP1 gene duplications. The study examined 16 PMD Patients ranging in age from 7 to 48 years, who had a documented PLP1 gene duplication. The study examined and analyzed the medical and developmental histories of the subjects utilizing a combination of resources that included medical history questionnaires, medical record reviews, and a 31‐point functional disability scale that had been previously validated. The data extracted from the medical records and questionnaires for analysis included information related to medical and developmental histories, level of ambulation and cognition, and degree of functional disability. The summation of findings among the study population demonstrated that the presenting symptoms, developmental milestones achieved, and progression of symptoms reported are consistent with many previous studies of patients with PLP1 duplications. All patients exhibited onset within the first year of life, with nystagmus predominating as the first symptom noticed. All patients exhibited delays in both motor and language development; however, many individuals were able to meet several developmental milestones. They exhibited some degree of continued motor impairment with none having the ability to walk independently. All patients were able to complete at least some of the cognition achievements and although not all were verbal, a number were able to use communication devices to complete these tasks. A critical tool of the study was the functional disability scale which provided a major advantage in helping quantify the clinical course of PMD, and for several, we were able to gather this information at more than one point in time. These reported findings in our cohort contribute important insight into the clinical heterogeneity and potential underlying mechanisms that define the molecular pathogenesis of the disease. This is one of only a small number of natural history studies examining the clinical course of a cohort of patients with PLP1 duplications within the context of a validated functional disability scoring system. This study is unique in that it is limited to subjects with PLP1 gene duplications. This study demonstrated many commonalities to other studies that have characterized the features of PMD and other PLP1‐related disorders but also provide significant new insights into the evolving story that marks the natural history.

Clinical and molecular genetic analysis of three pedigrees with Pelizaeus-Merzbacher-like disease

[Clinical and Genetic Analysis of a Family with Pelizaeus-Merzbacher Disease].

Combined Genetic and Imaging Diagnosis for Two Large Chinese Families Affected with Pelizaeus-Merzbacher Disease

Gene Mutations and Prenatal Diagnosis in Six Pedigrees with Pelizaeus-Merzbacher Disease

Study on proteolipid protein 1 gene mutation in a Chinese pedigree with Pelizaeus-Merzbacher disease

Two novel gap junction protein alpha 12 gene mutations in two Chinese patients with Pelizaeus-Merzbacher-like disease.

Identification and Functional Study of Novel PLP1 Mutations in Chinese Patients with Pelizaeus–Merzbacher Disease

Proteolipid Protein 1 Gene Mutation in Nine Patients with Pelizaeus-Merzbacher Disease

Prenatal Diagnosis of Two Families with Megalencephalic Leukoencephalopathy with Subcortical Cysts

Clinical Features and Molecular Genetic Analysis of a Pedigree of Limb Girdle Muscular Dystrophy

Genotype–phenotype Correlation and Natural History Analyses in a Chinese Cohort with Pelizaeus–merzbacher Disease

MRI Findings of Pelizaeus-Merzbacher Disease Correlated with Phenotypes and Genetic Mutation

Molecular Genetic Analysis of the PLP1 Gene in 38 Families with PLP1-related disorders: Identification and Functional Characterization of 11 Novel PLP1 Mutations

Identiﬁcation of GJC2 gene mutations in Chinese patients with Pelizaeus-Merzbacher-like disease.

Compound heterozygous mutations in POLR3A gene cause global developmental delay with epilepsy and striatal degeneration

Identification of Novel MLC1 Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC)

Ten Novel Mutations in Chinese Patients with Megalencephalic Leukoencephalopathy with Subcortical Cysts and a Long-Term Follow-Up Research.

Molecular confirmation of founder mutation c.-167A>G in Tunisian patients with PMLD disease

Identification of compound heterozygous mutations in GNPTG in three siblings of a Chinese family with mucolipidosis type III gamma.

The natural history of Pelizaeus–Merzbacher disease caused by PLP1 duplication: A multiyear case series

Case report: Analysis of a gene variant and prenatal diagnosis in a family with megalencephalic leukoencephalopathy with subcortical cysts